| Affiliation: | College of Pharmacy, University of North Texas System, Fort Worth, APhA Science Officer;Pharmacy Practice, Master of Public Health Program;College of Pharmacy, Nursing, and Allied Sciences, North Dakota State University, Fargo;College of Pharmacy, University of Arkansas for Medical Sciences, Little Rock, 2013–14 President APhA–APPM;College of Pharmacy, Washington State University, Spokane, 2012–14 President APhA–APRS;College of Pharmacy, University of Arkansas for Medical Sciences, Little Rock, 2013–14 National President APhA–ASP;PGY1 Community Pharmacy Residency Program, University of North Carolina (UNC) Eshelman School of Pharmacy, Chapel Hill;Duquesne University Mylan School of Pharmacy and Giant Eagle Pharmacy, Pittsburgh, PA; at the time of this project, she was PGY2 Community Pharmacy/Academic Resident at UNC Eshelman School of Pharmacy and Kerr Drug, Chapel Hill;Kerr Drug, Chapel Hill, NC;University of Washington School of Pharmacy, Seattle; at the time of this project, she was Visiting Professor, UNC Eshelman School of Pharmacy, Chapel Hill;Ateb, Raleigh, NC; at the time of this project, she was Executive Vice President, Kerr Health, LLC, of Kerr Drug, Inc;Department of Family Medicine, School of Medicine, UNC, Chapel Hill;Clinical Diagnostic Strategies, Durham, NC; at the time of this project she was Vice President of Clinical Development, Laboratory Corporation of America Holdings;Moffitt Cancer Center, Tampa, FL; at the time of this project he was UNC Eshelman Distinguished Professor of Pharmacy and Medicine, UNC, Chapel Hill;UNC Eshelman School of Pharmacy and Clinical Assistant Professor, UNC Department of Family Medicine, Chapel Hill;West Coast University School of Pharmacy, Los Angeles, CA;College of Pharmacy, Touro University California, Vallejo;College of Pharmacy, Touro University California, Vallejo;College of Pharmacy, Touro University California, Vallejo;College of Pharmacy, Touro University California, Vallejo;College of Pharmacy, Touro University California, Vallejo;College of Pharmacy, Touro University California, Vallejo;College of Pharmacy, University of Texas at Austin;College of Pharmacy, University of Texas at Austin;College of Pharmacy, University of Texas at Austin;College of Pharmacy, University of Texas at Austin;University of Texas at El Paso–University of Texas at Austin Cooperative Pharmacy Program, El Paso;CommUnityCare Health Centers, Austin, TX;CommUnityCare Health Centers, Austin, TX;CommUnityCare Health Centers, Austin, TX;CommUnityCare Health Centers, Austin, TX;CommUnityCare Health Centers, Austin, TX;graduate student at the time this study was conducted; currently Orise Fellow, Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville;Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville;Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville;Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville;Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville |
